Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
165,547,872
-
Total 13F shares
-
54,245,198
-
Share change
-
+466,187
-
Total reported value
-
$234,877,521
-
Put/Call ratio
-
138%
-
Price per share
-
$4.33
-
Number of holders
-
104
-
Value change
-
-$5,208,112
-
Number of buys
-
41
-
Number of sells
-
66
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) as of Q4 2021
As of 31 Dec 2021 CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) had 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 54,245,198 shares of stock of the company.
Largest 10 holders included Point72 Asset Management, L.P., RTW INVESTMENTS, LP, BVF INC/IL, VANGUARD GROUP INC, BlackRock Inc., ORBIMED ADVISORS LLC, STATE STREET CORP, Rubric Capital Management LP, Candriam Luxembourg S.C.A., and MILLENNIUM MANAGEMENT LLC.
This table shows 104 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.